# Scientists Uncover Molecular Mechanism Behind Statin-Induced Muscle Pain

Researchers identify how statin molecules trigger calcium leaks in muscle cells.

- **Source:** [Latest Science News -- ScienceDaily](https://brifing.si/source/0eef8637-6c5b-4e79-8f5b-6c9c6b36cf16)
- **Published:** 2026-10-20
- **Topic:** [Business](https://brifing.si/c/business)
- **Original article:** <https://www.sciencedaily.com/releases/2026/10/261019093447.htm>
- **On Brifing:** https://brifing.si/s/40e88b7d-1433-4904-9c91-01e237f07618

## Statin Safety and Limitations

Statins are essential for preventing cardiovascular disease by lowering cholesterol levels for millions globally. Despite their life-saving benefits, many patients report muscle pain, weakness, or rare but severe muscle breakdown. These side effects often lead patients to discontinue treatment, increasing their long-term risk of heart attacks and strokes significantly.

## Molecular Interaction Mechanism

Researchers at the University of British Columbia identified how statins interact with the ryanodine receptor, a protein regulating calcium movement. Using cryo-electron microscopy, they observed that statins hold this calcium channel open. This continuous leakage of calcium into muscle cells creates the conditions responsible for tissue injury and patient discomfort.

## Three-Molecule Binding Process

The study revealed an unusual binding pattern where three statin molecules occupy a specific pocket within the calcium channel protein. The first molecule initiates the opening, while two additional molecules stabilize this open state. This structural discovery explains why current statin medications inadvertently interfere with normal muscle cell calcium regulation processes.

## Atorvastatin and Drug Families

While the investigation focused primarily on atorvastatin, a widely prescribed cholesterol-lowering drug, the findings suggest similar interactions across the broader statin family. This indicates that the observed muscle-related complications are likely a shared characteristic of these medications, rather than an isolated issue specific to one single drug formulation or brand.

## Advanced Imaging Technology

Achieving this level of detail required high-resolution cryo-electron microscopy at the University of British Columbia. This advanced imaging method allowed scientists to visualize protein structures almost atom by atom. By mapping these interactions precisely, the team successfully connected long-standing drug safety concerns to a specific, observable molecular process within cells.

## Future Drug Development Roadmap

This research provides a clear roadmap for pharmaceutical developers to design safer statins. By modifying the specific features of the molecules that bind to muscle proteins, scientists may eliminate unwanted side effects. The goal is to maintain the cholesterol-lowering efficacy of the drugs while preventing the harmful interaction with muscle tissue.

## Impact on Patient Adherence

More than 200 million people worldwide rely on statins for heart health. Although severe injuries are rare, widespread soreness and fatigue disrupt daily life for many users. Developing more tolerable medications could significantly improve patient adherence, ensuring that individuals continue their prescribed treatments without fearing the debilitating side effects of therapy.

## Translating Research to Treatment

While these findings in Nature Communications represent a major scientific breakthrough, further research is required before new medications reach the market. The discovery offers a promising direction for future drug development. Ultimately, this work aims to enhance the safety profile of cardiovascular care, improving the overall quality of life for patients.

## Sources covering this story

- https://www.sciencedaily.com/releases/2026/10/261019093447.htm — 

---

_Summary written by Brifing from the original reporting. Copyright in the original article belongs to its publisher; read the full piece at the link above._
